EUVIMEDEUVIMED entdecken
Fallbericht

Late diagnosis of hyperphosphatemic familial tumoral calcinosis in an adult male: lessons from a misclassified case

Ayatallah Abu Jami iD, Omar Ismail iD, Fatima Alnaimat iD

Modern Rheumatology Case Reports · 2025

DOI: 10.1093/mrcr/rxaf079 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, 2025. Verfasst von Ayatallah Abu Jami und 2 weiteren Autor:innen. Beteiligte Einrichtung: aDepartment of Internal Medicine, Jordan University Hospital, Queen Rania Street, Amman 11941, Jordan. Hauptthemen laut MEDLINE: Hyperphosphatemia, Calcinosis, Hyperostosis, Cortical, Congenital. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare autosomal recessive disorder caused by multiple genetic mutations; all leading to reduced FGF23 function. It is characterised by hyperphosphatemia, ectopic calcifications, and signs of systemic inflammation. We describe a case of a 33-year-old male patient, previously diagnosed to have tumoral calcinosis due to multiple calciferous masses, who presented with polyarthritis involving the joints of the hands. He was managed by multiple surgical resections, after which the masses and symptoms recurred. He lost follow-up for 16 years before presenting to our clinic. The identification of elevated serum phosphate levels and a sibling with similar symptoms guided the diagnosis of HFTC. The patient was started on a low phosphate diet, sevelamer, and acetazolamide, and was instructed to avoid calcium and vitamin D supplements. Intravenous Zoledronic Acid was also given. The patient reported improvement in his symptoms in the follow-up visits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperphosphatemiaCalcinosisHyperostosis, Cortical, CongenitalHumansMaleAdultFibroblast Growth Factor-23Delayed Diagnosis

Stichwörter der Autor:innen

Hyperphosphatemic familial tumoral calcinosisectopic calcificationsfibroblast growth factor 23hyperphosphatemiatumoral calcinosis

Substanzen

Fibroblast Growth Factor-23FGF23 protein, human

Autor:innen und Institutionen

  • aDepartment of Internal Medicine, Jordan University Hospital, Queen Rania Street, Amman 11941, Jordan.
  • School of Medicine, Queen Rania Street, Amman 11941, Jordan.
  • Department of Internal Medicine, Division of Rheumatology, School of Medicine, The University of Jordan, Queen Rania Street, Amman 11941, Jordan.

ORCID-Profile: Ayatallah Abu Jami, Omar Ismail, Fatima Alnaimat

Zitieren

APA

Jami, A. A., Ismail, O., & Alnaimat, F. (2025). Late diagnosis of hyperphosphatemic familial tumoral calcinosis in an adult male: lessons from a misclassified case. Modern Rheumatology Case Reports. https://doi.org/10.1093/mrcr/rxaf079

Vancouver

Jami AA, Ismail O, Alnaimat F. Late diagnosis of hyperphosphatemic familial tumoral calcinosis in an adult male: lessons from a misclassified case. Modern Rheumatology Case Reports. 2025. doi:10.1093/mrcr/rxaf079

BibTeX
@article{Jami2025,
  author = {Jami, Ayatallah Abu and Ismail, Omar and Alnaimat, Fatima},
  title = {Late diagnosis of hyperphosphatemic familial tumoral calcinosis in an adult male: lessons from a misclassified case},
  journal = {Modern Rheumatology Case Reports},
  year = {2025},
  doi = {10.1093/mrcr/rxaf079}
}
Kostenlos starten →